CMAC 2000; 2(1) | CMAC

CMAC 2000; 2(1)

Many emerging and reemerging bacterial pathogens synthesize toxins that serve as primary virulence factors. We highlight seven …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):4-15
PDF

This review is devoted to the one of the actual problems of modern medicine - nosocomial infections (NI). Criteria, epidemiology, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):16-30
PDF

Objective. Introduction Azithromycinis anazalide with high activity against most frequent pathogens causing respiratory …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):31-36
PDF

The WHO Model List of Essential Drugs is eagerly awaited in many countries as a guide to what should be provided for basic health …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):37-46
PDF

The macrolide class of antibiotics is well established and often recommended for use in the treatment of community-acquired respiratory …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):47-58
PDF

Pathogens causing “atypical pneumonias” – mycoplasmas, legionellae, clamydiae, coxiellae play significant role in human infections. In …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):60-68
PDF

The present guidelines for clinical practice suggest preferable approaches to the problem of antibacterial therapy of acute …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):69-76
PDF

The present guidelines for clinical practice suggest preferable approaches to the problem of antibacterial therapy pneumonia in …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):77-87
PDF

These guidelines are focused on one of the most frequent bacterial pathogen causing communityacquired infections – Streptococcus …
Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):88-98
PDF